Free Trial

Billiontoone (BLLN) Competitors

Billiontoone logo
$98.36 +4.11 (+4.36%)
Closing price 06/3/2026 04:00 PM Eastern
Extended Trading
$98.08 -0.28 (-0.28%)
As of 08:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BLLN vs. GH, FMS, BTSG, CELC, and HIMS

Should you buy Billiontoone stock or one of its competitors? MarketBeat compares Billiontoone with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Billiontoone include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does Billiontoone compare to Guardant Health?

Billiontoone (NASDAQ:BLLN) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Billiontoone presently has a consensus target price of $125.29, suggesting a potential upside of 27.37%. Guardant Health has a consensus target price of $136.37, suggesting a potential upside of 7.35%. Given Billiontoone's higher possible upside, research analysts plainly believe Billiontoone is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.95

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Billiontoone has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M14.83$7.45M$0.55178.84
Guardant Health$982.02M17.15-$416.28M-$3.39N/A

Billiontoone has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
Guardant Health -40.10%N/A -26.42%

In the previous week, Guardant Health had 9 more articles in the media than Billiontoone. MarketBeat recorded 11 mentions for Guardant Health and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.38 beat Guardant Health's score of 0.28 indicating that Billiontoone is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Guardant Health beats Billiontoone on 8 of the 15 factors compared between the two stocks.

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Billiontoone (NASDAQ:BLLN) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Billiontoone presently has a consensus target price of $125.29, suggesting a potential upside of 27.37%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, suggesting a potential upside of 34.00%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Billiontoone's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

In the previous week, Billiontoone and Billiontoone both had 2 articles in the media. Billiontoone's average media sentiment score of 1.38 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that Billiontoone is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Billiontoone. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M14.83$7.45M$0.55178.84
Fresenius Medical Care AG & Co. KGaA$22.20B0.51$1.11B$1.9011.00

Summary

Fresenius Medical Care AG & Co. KGaA beats Billiontoone on 8 of the 13 factors compared between the two stocks.

How does Billiontoone compare to BrightSpring Health Services?

Billiontoone (NASDAQ:BLLN) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

BrightSpring Health Services has a net margin of 2.27% compared to Billiontoone's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
BrightSpring Health Services 2.27%14.63%4.41%

In the previous week, BrightSpring Health Services had 1 more articles in the media than Billiontoone. MarketBeat recorded 3 mentions for BrightSpring Health Services and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.38 beat BrightSpring Health Services' score of 1.15 indicating that Billiontoone is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Billiontoone currently has a consensus price target of $125.29, suggesting a potential upside of 27.37%. BrightSpring Health Services has a consensus price target of $57.64, suggesting a potential downside of 5.32%. Given Billiontoone's higher possible upside, equities analysts clearly believe Billiontoone is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12

BrightSpring Health Services has higher revenue and earnings than Billiontoone. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M14.83$7.45M$0.55178.84
BrightSpring Health Services$12.91B0.91$190.67M$1.4143.18

Summary

BrightSpring Health Services beats Billiontoone on 10 of the 14 factors compared between the two stocks.

How does Billiontoone compare to Celcuity?

Billiontoone (NASDAQ:BLLN) and Celcuity (NASDAQ:CELC) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Billiontoone presently has a consensus target price of $125.29, indicating a potential upside of 27.37%. Celcuity has a consensus target price of $152.09, indicating a potential upside of 70.98%. Given Celcuity's stronger consensus rating and higher possible upside, analysts clearly believe Celcuity is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83

63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Billiontoone's return on equity of 0.00% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
Celcuity N/A -244.61%-50.22%

In the previous week, Celcuity had 20 more articles in the media than Billiontoone. MarketBeat recorded 22 mentions for Celcuity and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.38 beat Celcuity's score of -0.13 indicating that Billiontoone is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celcuity
3 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
4 Very Negative mention(s)
Neutral

Billiontoone has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M14.83$7.45M$0.55178.84
CelcuityN/AN/A-$177.04M-$3.90N/A

Summary

Billiontoone beats Celcuity on 7 of the 13 factors compared between the two stocks.

How does Billiontoone compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hims & Hers Health presently has a consensus target price of $28.70, indicating a potential upside of 4.40%. Billiontoone has a consensus target price of $125.29, indicating a potential upside of 27.37%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts plainly believe Billiontoone is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Billiontoone has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
Billiontoone N/A N/A N/A

In the previous week, Hims & Hers Health had 22 more articles in the media than Billiontoone. MarketBeat recorded 24 mentions for Hims & Hers Health and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.38 beat Hims & Hers Health's score of 0.84 indicating that Billiontoone is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
8 Very Positive mention(s)
8 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has higher revenue and earnings than Billiontoone. Hims & Hers Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B2.71$128.37M-$0.09N/A
Billiontoone$305.11M14.83$7.45M$0.55178.84

Summary

Billiontoone beats Hims & Hers Health on 8 of the 15 factors compared between the two stocks.

Get Billiontoone News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLLN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLLN vs. The Competition

MetricBilliontooneServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$4.34B$1.49B$1.02B$12.54B
Dividend YieldN/AN/A4.78%5.22%
P/E Ratio178.8414.988.9624.18
Price / Sales14.835.5161.94112.26
Price / Cash291.182,870.74335.1657.13
Price / Book9.3935.716.666.72
Net Income$7.45M-$26.94M-$13.24M$337.19M
7 Day Performance0.57%0.77%-0.46%-0.75%
1 Month PerformanceN/AN/A4.95%-1.69%
1 Year PerformanceN/AN/A48.83%33.09%

Billiontoone Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLLN
Billiontoone
4.6522 of 5 stars
$98.36
+4.4%
$125.29
+27.4%
N/A$4.34B$305.11M178.84620
GH
Guardant Health
2.1177 of 5 stars
$129.69
-2.6%
$129.79
+0.1%
+177.4%$17.66B$1.08BN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
4.6708 of 5 stars
$21.56
-0.3%
$28.00
+29.9%
-26.3%$12.08B$19.36B11.341,488
BTSG
BrightSpring Health Services
3.8725 of 5 stars
$61.68
+1.4%
$57.00
-7.6%
+157.4%$11.80B$12.91B43.7423,500
CELC
Celcuity
2.9463 of 5 stars
$132.88
+1.5%
$150.27
+13.1%
+645.0%$6.38BN/AN/A40

Related Companies and Tools


This page (NASDAQ:BLLN) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners